Related Experiment Video
Updated: Jul 25, 2026

10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
Summary
Brain scintigraphy effectively detects medulloblastoma recurrence and metastasis in treated patients. This sensitive and specific imaging test aids in identifying posterior fossa recurrence and supratentorial spread, crucial for patient management.
Area of Science:
- Neuro-oncology
- Diagnostic Imaging
- Pediatric Oncology
Background:
- Medulloblastoma is a common pediatric brain tumor requiring vigilant follow-up.
- Recurrence and metastasis pose significant challenges in managing treated medulloblastoma patients.
- Accurate detection of disease spread is vital for timely therapeutic adjustments.
Purpose of the Study:
- To evaluate the diagnostic utility of brain scintigraphy in detecting recurrence and metastasis in patients with previously treated medulloblastoma.
- To assess the sensitivity and specificity of brain scintigraphy for posterior fossa recurrence and supratentorial metastases.
Main Methods:
- Brain scintigraphy was performed on 23 patients with a history of treated medulloblastoma.
- Scintigraphic findings were compared with other available diagnostic evidence.
- Diagnostic agreement rates for posterior fossa recurrence and supratentorial masses were calculated.
Main Results:
- Brain scintigraphy identified posterior fossa recurrence in 15 patients and supratentorial metastases in 9.
- Only one case of supratentorial metastasis was clinically suspected prior to imaging.
- High agreement was observed between scintigraphy and other diagnostic methods (93% for posterior fossa, 80% for supratentorial).
Conclusions:
- Brain scintigraphy demonstrates high sensitivity and specificity for detecting medulloblastoma recurrence and metastasis.
- The technique is valuable for identifying both posterior fossa recurrence and unexpected supratentorial spread.
- This imaging modality aids in comprehensive assessment of disease status in treated medulloblastoma patients.

